
Full profile: /officials/C001119
Source: Congress.gov · FEC
Members who have signed on to support this bill since introduction. Source: Congress.gov.
The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
2025-11-21
Source: Congress.gov
Currently in
Previously
The proposal would make insulin more affordable for Americans by capping what patients have to pay out of pocket for the medication, likely through price controls or insurance coverage requirements. This would primarily affect diabetics who depend on insulin to manage their condition, as well as insurance companies and pharmaceutical manufacturers. The bill is currently being reviewed by three House committees to determine which parts fall under their areas of responsibility.
AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.
Bills by the same sponsor or covering overlapping subjects.